Attachment 3 Program Description

#3 Program Description.doc

Centers for Disease Control and Prevention Performance Evaluation Program for Mycobacterium Tuberculosis/Non-tuberculosis Mycobacteria Drug Susceptibility Testing Program

Attachment 3 Program Description

OMB: 0920-0600

Document [doc]
Download: doc | pdf


Model Performance Evaluation Program: Mycobacterium tuberculosis and Non-tuberculous Mycobacteria (NTM) Drug Susceptibility Testing Enrollment Form


Open to all U.S. and qualifying International Laboratories.

Enrollment for laboratories outside of the U.S. is restricted to national reference laboratories or selected regional public health laboratories.

Please provide the following contact information: (* indicates required information)


Name* _______________________________________

Title* _______________________________________

Lab Name* _______________________________________

Street address* _______________________________________

Address (cont.) _______________________________________

City* ____________________ State/Province* _____________________

Zip/Postal code* ____________________ Country* ___________________________

Work Phone* ____________________ FAX* ______________________________

E-mail _______________________________________


Please provide the following shipping information (overnight courier), if different from the contact information specified above or if the address specified above is a post office box (PO Box) - isolates cannot be shipped to a P.O. Box


Name _______________________________________

Title _______________________________________

Street address _______________________________________

Address (cont.) _______________________________________

City* ____________________ State/Province* _____________________

Zip/Postal code* ____________________ Country* ___________________________

Work Phone* ____________________ FAX* ______________________________

E-mail _______________________________________


Public reporting of this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-24, Atlanta, Georgia 30333; ATTN: PRA (0920-XXX)


Page 2


1) Does your laboratory conduct diagnostic testing for Mycobacterium tuberculosis? *
Yes No


2) Does your laboratory perform Mycobacterium tuberculosis drug susceptibility testing? *
Yes No


If YES, does your laboratory follow Biosafety Level III practices in performing Mycobacterium tuberculosis susceptibility testing? *
Yes   No

4) Does your laboratory conduct onsite susceptibility testing of NTM? *
Yes No


5) Which of the following performance evaluation samples would your laboratory like to receive? *
M. tb only        NTM only      Both M. tb & NTM

6) Select the primary classification of your laboratory:*
Hospital    Independent   Health Department    Other




Laboratories Outside of the United States please answer the following:

7) Does your laboratory function as a National M. tb reference laboratory

Yes No


8) Is your laboratory part of a national M. tb susceptibility testing network?

Yes No


9) Does your country have any restrictions regarding the transport/receipt of infectious agents which may require obtaining an important permit?

Yes No


IF YES, your laboratory will be responsible for obtaining this permit and forwarding a copy to us for our use.



File Typeapplication/msword
File TitleModel Performance Evaluation Program Mycobacterium tuberculosis Drug Susceptibility and NTM Testing Performance Evaluation Enr
Authornel5
Last Modified ByPHPPO_User
File Modified2006-09-19
File Created2003-05-27

© 2024 OMB.report | Privacy Policy